Live Quote · NASDAQSLGLHealthcare· Biotechnology

Sol-Gel Technologies Ltd.

$74.01 2.81%(+$2.02)
TickerSpark Score
63/100
Mixed
50
Valuation
40
Profitability
55
Growth
68
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SLGL research report →

52-Week Range74% of range
Low
$6.96
Current
$74.01
High
$97.97
Company Overviewwww.sol-gel.com

About the company

Sol-Gel Technologies Ltd. , a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel.

CEO
Moshe Arkin
IPO
2018
Employees
34
HQ
Ness Ziona, IL

Price Chart

+890.76% · this period
$97.97$52.49$7.01Jul 02Dec 31Jul 02
Valuation
Market Cap
$207.96M
P/E
-217.68
P/S
11.26
P/B
4.08
EV/EBITDA
-100.45
Div Yield
0.00%
Profitability
Gross Margin
100.00%
Op Margin
-12.59%
Net Margin
-5.66%
ROE
-3.17%
ROIC
-4.41%
Growth & Income
Revenue
$19.39M · 68.04%
Net Income
$-6,127,000 · 42.09%
EPS
$-2.20 · -478.95%
Op Income
$-7,538,000
FCF YoY
101.98%
Performance & Tape
52W High
$97.97
52W Low
$6.96
50D MA
$72.82
200D MA
$59.38
Beta
1.13
Avg Volume
38.57K

Get TickerSpark's AI analysis on SLGL

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jul 2, 26Opaleye Management Inc.buy1,400
Jul 1, 26Opaleye Management Inc.buy312
May 20, 26Opaleye Management Inc.buy1,563
May 13, 26Opaleye Management Inc.buy1,937
May 12, 26Opaleye Management Inc.buy1,500
Mar 24, 26Opaleye Management Inc.buy34,665
Mar 24, 26Opaleye Management Inc.buy5,000
Mar 18, 26Yosef Itzikother2,031
Mar 18, 26Yosef Itzikother566
Mar 18, 26Yosef Itzikother499
Coverage · SLGL

Our SLGL coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on SLGL yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate SLGL report →
Internal Compare

Similar companies

Peers in the same neighborhood.